These figures summarise how HCG is commonly described in research literature and supplier documentation
Looking for further guidance on how to treat obesity beyond medications such as semaglutide and tirzepatide
100 percent subcutaneous | | Reported weight data | 12.4 % (36 mg, 72 wk, ATTAIN-1) | 24.2 % (12 mg, 48 wk, Phase 2) | | Food restriction | None | Not applicable | | Status | FDA-approved (Foundayo, April 2026) | Research substance, not approved | The table illustrates that the higher weight values of retatrutide result from a broader receptor activation and the injection-driven complete entry of the active substance, while orforglipron has its strength in ease of administration and oral availability
Semaglutide has become an exciting choice for folks wanting to meet their weight loss goals and get healthier overall
Your energy crashes in the afternoon regardless of how much you sleep
You should avoid taking semaglutide if : You are pregnant , planning to become pregnant soon, or breastfeeding You have a personal or family history of medullary thyroid carcinoma (a rare type of thyroid cancer)